Journal
ANNALS OF MEDICINE
Volume 38, Issue 7, Pages 493-502Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/07853890600982737
Keywords
atherosclerosis; angioplasty; BLT receptors; CysLT receptors; eicosanoids; inflammation; lipoxygenase
Categories
Ask authors/readers for more resources
Leukotriene-forming enzymes are expressed within atherosclerotic lesions and locally produced leukotrienes exert pro-inflammatory actions within the vascular wall by means of cell surface receptors of the BLT and CysLT receptor subtypes. The migration and accumulation of inflammatory cells that follow leukotriene receptor activation have been implicated in atherosclerosis initiation and progression. Leukotriene receptors are in addition expressed on endothelial and vascular smooth muscle cells, associated with intimal hyperplasia in early atherosclerosis and restenotic lesions after angioplasty. Taken together, recent evidence suggests that leukotriene receptors may be a potential target in the treatment of atherosclerosis and in the prevention of restenosis after coronary interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available